Shares of Pharmicell, which operates in the stem cell therapy business, showed strength during trading on the 24th. The news that it plans to build a third factory in Ulsan seems to have stimulated investor sentiment.
Pharmicell shares traded at 11,750 won on the Korea Composite Stock Price Index (KOSPI) market at 2:41 p.m. The stock price rose by 2.8% (320 won) compared to the previous trading day. During trading, the stock price even jumped to 12,250 won.
Pharmicell announced during trading that it will invest 30 billion won to establish its third factory in Ulsan. Pharmicell explained that it decided to build the factory to meet large-scale demand for advanced industrial materials and pharmaceutical raw materials using artificial intelligence (AI). Pharmicell plans to complete the construction of the third factory by September 2026.